Skip to main content
OABI
NASDAQ Industrial Applications And Services

OmniAb Reports 29% Revenue Decline, Increased Net Loss, and Completes Dilutive $30M Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.75
Mkt Cap
$260.559M
52W Low
$1.22
52W High
$3.46
52W Position info
43% above low
Off High info
49% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

OABI sits 43% above its 52-week low of $1.22.

Summary

OmniAb, Inc. reported a significant 29% year-over-year revenue decrease to $18.7 million and an increased net loss of $64.8 million for 2025, alongside a dilutive $30 million private placement to bolster liquidity.


Key Events · Earnings and Guidance · OABI

  • Revenue Plunges 29%

    Total revenue for 2025 decreased by 29% to $18.7 million, down from $26.4 million in 2024.

  • Net Loss Widens

    The company reported an increased net loss of $64.8 million in 2025, compared to a net loss of $62.0 million in 2024.

  • Dilutive Private Placement Completed

    OmniAb completed a $30.0 million private placement in August 2025, issuing 21,254,106 common shares at prices between $1.40 and $1.85 per share, representing significant dilution to existing shareholders.

  • Asset Impairments and Restructuring

    The company recorded $3.3 million in impairment charges related to ion channel property and equipment and an additional $0.6 million for prepaid research technology. Restructuring actions in 2025 led to $1.9 million in charges and impacted 22 employees.


Analysis · OABI · Industrial Applications And Services

The 2025 annual report reveals substantial financial challenges for OmniAb, Inc., marked by a significant revenue contraction and widening net losses. The company's reliance on a dilutive private placement at a low share price underscores its need for capital to sustain operations, despite a slight improvement in cash burn from operating activities. The asset impairment charges and restructuring efforts further highlight operational difficulties. Investors should note the high customer concentration and the out-of-the-money warrants, which limit future non-dilutive financing options. The company's ability to achieve profitability and reduce its dependence on external financing remains a key concern.

At the time of this filing, OABI was trading at $1.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $260.6M. The 52-week trading range was $1.22 to $3.46. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OABI - Latest Insights

OABI
May 07, 2026, 4:25 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.47
Real-time Price: $1.97 info
Change: +$0.500 (+34%) info
Market Cap: $285.596M info
OABI
May 07, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1.47
Real-time Price: $1.97 info
Change: +$0.500 (+34%) info
Market Cap: $285.596M info
OABI
Mar 04, 2026, 4:28 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $1.97 info
Change: +$0.220 (+13%) info
Market Cap: $285.596M info
OABI
Mar 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $1.97 info
Change: +$0.220 (+13%) info
Market Cap: $285.596M info